Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 12/2016

Open Access 01-12-2016 | Original Article – Clinical Oncology

Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer

Authors: Junzhong Lin, Jianhong Peng, Aiham Qdaisat, Liren Li, Gong Chen, Zhenhai Lu, Xiaojun Wu, Yuanhong Gao, Zhifan Zeng, Peirong Ding, Zhizhong Pan

Published in: Journal of Cancer Research and Clinical Oncology | Issue 12/2016

Login to get access

Abstract

Purpose

In addition to tumor factors, poor nutritional status before and during anti-tumor treatment might compromise prognosis in several types of cancer. This study was done to determine the impact of weight loss during preoperative chemoradiotherapy (CRT) on the survival outcome of patients with locally advanced rectal cancer (LARC).

Methods

The retrospective study examined consecutive patients with LARC who underwent preoperative CRT followed by radical resection in a single institute, between 2003 and 2013. Correlation of proportional body mass index (BMI) change after preoperative CRT and patient’s demographics, tumor characteristics, treatment parameters, CRT-related toxicity, disease-free survival (DFS) and overall survival (OS) were investigated.

Results

A total of 364 patients were enrolled, and BMI loss was found in 243 patients (66.2 %) after preoperative CRT. Severe weight loss (SWL) was defined as BMI loss ≥7 %. Thirty-nine (10.7 %) cases were enrolled in SWL cohort and found to have higher incidence of diarrhea (P = 0.033), renal disorder (P = 0.033) and grade 3–4 radiation proctitis (P = 0.041). Although no significant difference was found in 3-year DFS, patients in SWL cohort showed significantly worse 3-year OS rate (71.8 vs 88.0 %, P = 0.030) than the others. In univariate analysis, BMI loss ≥7 %, completed dose of preoperative chemotherapy, pathologic T and N stages were correlated with OS (all P < 0.05). In multivariable analysis, BMI loss ≥7 % (HR 1.984; 95 % CI 1.061–3.709; P = 0.032) remained the independent prognostic factor for OS.

Conclusions

Our results demonstrate that SWL during preoperative CRT indeed compromises survival outcome in patients with LARC. Routine nutritional monitoring and nutritional support during preoperative CRT are suggested as the integral part of the multidisciplinary approach for these patients.
Literature
go back to reference Arrieta O et al (2010) Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer 10:50. doi:10.1186/1471-2407-10-50 CrossRefPubMedPubMedCentral Arrieta O et al (2010) Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer 10:50. doi:10.​1186/​1471-2407-10-50 CrossRefPubMedPubMedCentral
go back to reference Campbell PT, Newton CC, Dehal AN, Jacobs EJ, Patel AV, Gapstur SM (2012) Impact of body mass index on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol 30:42–52. doi:10.1200/JCO.2011.38.0287 CrossRefPubMed Campbell PT, Newton CC, Dehal AN, Jacobs EJ, Patel AV, Gapstur SM (2012) Impact of body mass index on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol 30:42–52. doi:10.​1200/​JCO.​2011.​38.​0287 CrossRefPubMed
go back to reference Dalal S et al (2012) Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study. J Pain Symptom Manag 44:181–191. doi:10.1016/j.jpainsymman.2011.09.010 CrossRef Dalal S et al (2012) Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study. J Pain Symptom Manag 44:181–191. doi:10.​1016/​j.​jpainsymman.​2011.​09.​010 CrossRef
go back to reference Diaz-Gonzalez JA et al (2006) Prognostic factors for disease-free survival in patients with T3–4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation. Int J Radiat Oncol 64:1122–1128. doi:10.1016/j.ijrobp.2005.09.020 CrossRef Diaz-Gonzalez JA et al (2006) Prognostic factors for disease-free survival in patients with T3–4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation. Int J Radiat Oncol 64:1122–1128. doi:10.​1016/​j.​ijrobp.​2005.​09.​020 CrossRef
go back to reference Hede P, Sorensson MA, Polleryd P, Persson K, Hallgren T (2015) Influence of BMI on short-term surgical outcome after colorectal cancer surgery: a study based on the Swedish national quality registry. Int J Colorectal Dis 30:1201–1207. doi:10.1007/s00384-015-2280-0 CrossRefPubMed Hede P, Sorensson MA, Polleryd P, Persson K, Hallgren T (2015) Influence of BMI on short-term surgical outcome after colorectal cancer surgery: a study based on the Swedish national quality registry. Int J Colorectal Dis 30:1201–1207. doi:10.​1007/​s00384-015-2280-0 CrossRefPubMed
go back to reference Mandard AM et al (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73:2680–2686CrossRefPubMed Mandard AM et al (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73:2680–2686CrossRefPubMed
go back to reference Matsuo K, Moeini A, Cahoon SS, Machida H, Ciccone MA, Grubbs BH, Muderspach LI (2016) Weight change pattern and survival outcome of women with endometrial cancer. Ann Surg Oncol. doi:10.1245/s10434-016-5237-9 Matsuo K, Moeini A, Cahoon SS, Machida H, Ciccone MA, Grubbs BH, Muderspach LI (2016) Weight change pattern and survival outcome of women with endometrial cancer. Ann Surg Oncol. doi:10.​1245/​s10434-016-5237-9
go back to reference Ravasco P, Monteiro-Grillo I, Camilo M (2012) Individualized nutrition intervention is of major benefit to colorectal cancer patients: long-term follow-up of a randomized controlled trial of nutritional therapy. Am J Clin Nutr 96:1346–1353. doi:10.3945/ajcn.111.018838 CrossRefPubMed Ravasco P, Monteiro-Grillo I, Camilo M (2012) Individualized nutrition intervention is of major benefit to colorectal cancer patients: long-term follow-up of a randomized controlled trial of nutritional therapy. Am J Clin Nutr 96:1346–1353. doi:10.​3945/​ajcn.​111.​018838 CrossRefPubMed
go back to reference Song KS et al (2011) Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling. Pancreatology 11:574–584. doi:10.1159/000334468 CrossRefPubMed Song KS et al (2011) Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling. Pancreatology 11:574–584. doi:10.​1159/​000334468 CrossRefPubMed
go back to reference Uratani R et al (2015) Preoperative lower body mass index correlates with poorer prognosis in patients undergoing curative laparoscopic surgery for colorectal cancer. Anticancer Res 35:5639–5648PubMed Uratani R et al (2015) Preoperative lower body mass index correlates with poorer prognosis in patients undergoing curative laparoscopic surgery for colorectal cancer. Anticancer Res 35:5639–5648PubMed
Metadata
Title
Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer
Authors
Junzhong Lin
Jianhong Peng
Aiham Qdaisat
Liren Li
Gong Chen
Zhenhai Lu
Xiaojun Wu
Yuanhong Gao
Zhifan Zeng
Peirong Ding
Zhizhong Pan
Publication date
01-12-2016
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 12/2016
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-016-2225-1

Other articles of this Issue 12/2016

Journal of Cancer Research and Clinical Oncology 12/2016 Go to the issue